Therefore, this research investigated the correlation between GCDA, S1PR2, and NAFLD-HCC to present novel understandings of the prevention and treatment of NAFLD-HCC. This evidence concerns the gene S1PR2 and metabolic dysfunction-associated steatotic liver disease.